1 – 100 of 265
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
- Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
- Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
- Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition
- 2018
- Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
- Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation
- Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
- MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer
- Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels : Results from the EPIC cohort
- Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment
- Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 levels in normal-weight patients and improved prognosis following tamoxifen or radiotherapy treatment
- Tumor characteristics and prognosis in women with pregnancy-associated breast cancer
- Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases
- A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes
- Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
- Hormonal factors and pancreatic cancer risk in women : The Malmö Diet and Cancer Study
- Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
- Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma
- 2017
- The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
- Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
- Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
- Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
- Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
- Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker
- Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters
- Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer
- High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
- Prognostic value of HER3 and HER2 alterations in colorectal cancer: Relationship with sidedness, KRAS and BRAF mutation status
- Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
- The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
- The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
- The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype
- High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
- Infiltration of γδ T cells, IL-17 + T cells and FoxP3 + T cells in human breast cancer
- High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
- Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer : a Mendelian Randomization analysis using data from three large cohort studies
- Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer
- Coffee, tea and melanoma risk : findings from the European Prospective Investigation into Cancer and Nutrition
- 2016
- ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
- The prognostic impact of NK/NKT cell density in periampullary adenocarcinoma differs by morphological type and adjuvant treatment
- A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort
- Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
- Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
- Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
- Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
- Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
- Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
- Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
- Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
- Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma
- The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.
- Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
- Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
- Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study
- Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer
- Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
- Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma
- Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
- Pre-diagnostic meat and fibre intakes in relation to colorectal cancer survival in the European Prospective Investigation into Cancer and Nutrition
- Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
- 2015
- Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
- Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome.
- The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
- Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.
- Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
- Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
- Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
- BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.
- Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.
- Delineating Transcriptional Networks of Prognostic Gene Signatures Refines Treatment Recommendations for Lymph Node-negative Breast Cancer Patients.
- S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.
- Discordant HER2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
- Pre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients: a cohort study.
- The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.
- Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.
- Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.
- FKBPL: a marker of good prognosis in breast cancer.
- Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
- Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
- LRIG1 is a prognostic biomarker in non-small cell lung cancer
- Early diagnostic value of Bcl-3 localization in colorectal cancer.
- Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression.
- The clinicopathological and gene expression patterns associated with ulceration of primary melanoma
- Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
- Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer.
- Subtypes of fruit and vegetables, variety in consumption and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition.
- Fibre intake and incident colorectal cancer depending on fibre source, sex, tumour location and Tumour, Node, Metastasis stage.
- 2014
- Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.
- Coffee and tea consumption, genotype- based CYP1A2 and NAT2 activity and colorectal cancer risk- Results from the EPIC cohort study
- Investigation of molecular alterations of AKT-3 in triple-negative breast cancer
- A systematic analysis of commonly used antibodies in cancer diagnostics
- WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism.
- SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
- The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy.
- Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women : a cohort study
- Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
- Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
- Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
- C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation.
- 71p * statin-induced anti-proliferative effects via cyclin d1 and p27 in a window-of-opportunity breast cancer trial.